Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519226) titled 'Effectiveness and Safety of Penehyclidine Hydrochloride for Improving Microcirculatory Dysfunction in Critically Ill Children' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Lihua Wen
Condition:
Shock
Intervention:
Drug: atropine control group
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 8, 2024
Target Sample Size: 98
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07519226
Published by H...